ABBVIE INC. (ABBV)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$4.35 (-2.39%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of ABBVIE INC. (ABBV)
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

Key Insights

Critical company metrics and information

  • Share Price

    $177.37

  • Market Cap

    $313.44 Billion

  • Total Outstanding Shares

    1.77 Billion Shares

  • Total Employees

    50,000

  • Dividend

    $1.64 Per Share Quarterly

  • IPO Date

    December 10, 2012

  • SIC Description

    Pharmaceutical Preparations

  • Homepage

    http://www.abbvieinvestor.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Investing Activities, Continuing$-19.75 Billion
Net Cash Flow From Operating Activities, Continuing$16.51 Billion
Exchange Gains/Losses$4.00 Million
Net Cash Flow From Operating Activities$16.51 Billion
Net Cash Flow From Investing Activities$-19.75 Billion
Net Cash Flow From Financing Activities, Continuing$-2.80 Billion
Net Cash Flow, Continuing$-6.03 Billion
Net Cash Flow From Financing Activities$-2.80 Billion
Net Cash Flow$-6.03 Billion

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Income Tax Expense/Benefit, Deferred$-2.07 Billion
Revenues$55.53 Billion
Diluted Average Shares$5.32 Billion
Income/Loss From Continuing Operations Before Tax$20.29 Billion
Income/Loss From Continuing Operations After Tax$5.13 Billion
Operating Expenses$23.50 Billion
Preferred Stock Dividends And Other Adjustments$30.00 Million
Cost Of Revenue$18.21 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$30.00 Million
Net Income/Loss$5.13 Billion
Operating Income/Loss$13.82 Billion
Income Tax Expense/Benefit$2.06 Billion
Gross Profit$37.32 Billion
Diluted Earnings Per Share$2.87
Benefits Costs and Expenses$35.25 Billion
Basic Average Shares$5.31 Billion
Other Operating Expenses$9.41 Billion
Net Income/Loss Attributable To Noncontrolling Interest$9.00 Million
Selling, General, and Administrative Expenses$14.09 Billion
Net Income/Loss Attributable To Parent$5.12 Billion
Net Income/Loss Available To Common Stockholders, Basic$5.09 Billion
Interest Expense, Operating$2.67 Billion
Costs And Expenses$30.61 Billion
Basic Earnings Per Share$2.87

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Fixed Assets$5.14 Billion
Current Assets$27.79 Billion
Equity$6.07 Billion
Other Non-current Assets$43.85 Billion
Noncurrent Liabilities$94.29 Billion
Current Liabilities$43.06 Billion
Equity Attributable To Noncontrolling Interest$39.00 Million
Noncurrent Assets$115.64 Billion
Intangible Assets$66.65 Billion
Liabilities$137.35 Billion
Liabilities And Equity$143.42 Billion
Equity Attributable To Parent$6.03 Billion
Other Current Assets$23.34 Billion
Inventory$4.45 Billion
Assets$143.42 Billion

Historical Dividends

Current dividend: $1.64 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Oct 30, 2024Feb 14, 2025Jan 15, 2025$1.64Quarterly
Sep 6, 2024Nov 15, 2024Oct 15, 2024$1.55Quarterly
Jun 20, 2024Aug 15, 2024Jul 15, 2024$1.55Quarterly
Feb 15, 2024May 15, 2024Apr 15, 2024$1.55Quarterly
Oct 27, 2023Feb 15, 2024Jan 16, 2024$1.55Quarterly
Sep 8, 2023Nov 15, 2023Oct 13, 2023$1.48Quarterly
Jun 22, 2023Aug 15, 2023Jul 14, 2023$1.48Quarterly
Feb 16, 2023May 15, 2023Apr 14, 2023$1.48Quarterly
Oct 28, 2022Feb 15, 2023Jan 13, 2023$1.48Quarterly
Sep 9, 2022Nov 15, 2022Oct 14, 2022$1.41Quarterly
Jun 23, 2022Aug 15, 2022Jul 15, 2022$1.41Quarterly
Feb 17, 2022May 16, 2022Apr 15, 2022$1.41Quarterly
Oct 29, 2021Feb 15, 2022Jan 14, 2022$1.41Quarterly
Sep 10, 2021Nov 15, 2021Oct 15, 2021$1.3Quarterly
Jun 17, 2021Aug 16, 2021Jul 15, 2021$1.3Quarterly
Feb 18, 2021May 14, 2021Apr 15, 2021$1.3Quarterly
Oct 30, 2020Feb 16, 2021Jan 15, 2021$1.3Quarterly
Sep 11, 2020Nov 16, 2020Oct 15, 2020$1.18Quarterly
Jun 17, 2020Aug 14, 2020Jul 15, 2020$1.18Quarterly
Feb 20, 2020May 15, 2020Apr 15, 2020$1.18Quarterly
Nov 1, 2019Feb 14, 2020Jan 15, 2020$1.18Quarterly
Sep 6, 2019Nov 15, 2019Oct 15, 2019$1.07Quarterly
Jun 20, 2019Aug 15, 2019Jul 15, 2019$1.07Quarterly
Feb 21, 2019May 15, 2019Apr 15, 2019$1.07Quarterly
Nov 2, 2018Feb 15, 2019Jan 15, 2019$1.07Quarterly
Sep 7, 2018Nov 15, 2018Oct 15, 2018$0.96Quarterly
Jun 14, 2018Aug 15, 2018Jul 13, 2018$0.96Quarterly
Feb 15, 2018May 15, 2018Apr 13, 2018$0.96Quarterly
Oct 27, 2017Feb 15, 2018Jan 12, 2018$0.71Quarterly
Sep 8, 2017Nov 15, 2017Oct 13, 2017$0.64Quarterly
Jun 22, 2017Aug 15, 2017Jul 14, 2017$0.64Quarterly
Feb 16, 2017May 15, 2017Apr 13, 2017$0.64Quarterly
Oct 28, 2016Feb 15, 2017Jan 13, 2017$0.64Quarterly
Sep 9, 2016Nov 15, 2016Oct 14, 2016$0.57Quarterly
Jun 16, 2016Aug 15, 2016Jul 15, 2016$0.57Quarterly
Feb 18, 2016May 16, 2016Apr 15, 2016$0.57Quarterly
Oct 30, 2015Feb 16, 2016Jan 15, 2016$0.57Quarterly
Jun 18, 2015Aug 14, 2015Jul 15, 2015$0.51Quarterly
Feb 19, 2015May 15, 2015Apr 15, 2015$0.51Quarterly
Oct 20, 2014Feb 13, 2015Jan 15, 2015$0.49Quarterly
Sep 19, 2014Nov 17, 2014Oct 15, 2014$0.42Quarterly
Jun 19, 2014Aug 15, 2014Jul 15, 2014$0.42Quarterly
Feb 20, 2014May 15, 2014Apr 15, 2014$0.42Quarterly
Dec 12, 2013Feb 14, 2014Jan 15, 2014$0.4Quarterly
Sep 19, 2013Nov 15, 2013Oct 15, 2013$0.4Quarterly
Jun 20, 2013Aug 15, 2013Jul 15, 2013$0.4Quarterly
Feb 15, 2013May 15, 2013Apr 15, 2013$0.4Quarterly
Jan 4, 2013Feb 15, 2013Jan 15, 2013$0.4Quarterly

Related Companies

View additional S&P 500 companies similar to ABBVIE INC. (ABBV)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2024 Financhle. All Rights Reserved.